ClinicalTrials.gov
public full text
Public Domain
CDP323 Biomarker Study
Comparison of the effects of different CDP323 doses given over a period of four weeks on blood biomarkers in subjects with relapsing forms of multiple sclerosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis#1095701
- An Extension of the TG1101-RMS201 Trial#1352551
- Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging#898463
- Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS#1279832
- Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis#859774
Record · ID 1408297
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive